Guangqing Xiao

1.8k total citations
28 papers, 1.2k citations indexed

About

Guangqing Xiao is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Guangqing Xiao has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pediatrics, Perinatology and Child Health and 7 papers in Molecular Biology. Recurrent topics in Guangqing Xiao's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Guangqing Xiao is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Guangqing Xiao collaborates with scholars based in United States, China and Japan. Guangqing Xiao's co-authors include Liang‐Shang Gan, Kathleen M. Giacomini, Jashvant D. Unadkat, Xiaoyan Chu, Laurent Salphati, Richard E. Fine, Robin J. Johnson, Yurong Lai, Cornelis E. C. A. Hop and W. Griffith Humphreys and has published in prestigious journals such as Molecular Pharmacology, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Guangqing Xiao

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guangqing Xiao United States	20	555	386	308	262	156	28	1.2k
Cindy Q. Xia United States	20	777 1.4×	481 1.2×	307 1.0×	281 1.1×	56 0.4×	47	1.4k
Jason R. Manro United States	14	556 1.0×	420 1.1×	244 0.8×	323 1.2×	53 0.3×	28	1.3k
Marie V. St–Pierre Switzerland	24	987 1.8×	552 1.4×	489 1.6×	185 0.7×	230 1.5×	43	1.9k
Jun-ichi Sawada Japan	20	751 1.4×	696 1.8×	258 0.8×	243 0.9×	58 0.4×	42	1.4k
J.M. Scherrmann France	18	372 0.7×	530 1.4×	200 0.6×	144 0.5×	70 0.4×	53	1.4k
Tae Inoue Japan	18	499 0.9×	535 1.4×	171 0.6×	441 1.7×	100 0.6×	26	1.3k
Birk Poller Switzerland	20	684 1.2×	337 0.9×	257 0.8×	254 1.0×	90 0.6×	35	1.3k
Jason A. Sprowl United States	19	747 1.3×	315 0.8×	295 1.0×	151 0.6×	53 0.3×	34	1.2k
Anke Geick Germany	10	674 1.2×	407 1.1×	253 0.8×	481 1.8×	94 0.6×	11	1.3k
Serena Marchetti Netherlands	19	836 1.5×	577 1.5×	151 0.5×	155 0.6×	50 0.3×	48	1.4k

Countries citing papers authored by Guangqing Xiao

Since Specialization

Citations

This map shows the geographic impact of Guangqing Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangqing Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangqing Xiao more than expected).

Fields of papers citing papers by Guangqing Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangqing Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangqing Xiao. The network helps show where Guangqing Xiao may publish in the future.

Co-authorship network of co-authors of Guangqing Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Guangqing Xiao. A scholar is included among the top collaborators of Guangqing Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangqing Xiao. Guangqing Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Guangqing, et al.. (2024). Resveratrol Attenuates Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via TLR-4 Mediated Inflammation in C57BL/6 Mice. Physiological Research. 73(1/2024). 91–104. 13 indexed citations

Chen, Yu‐Luan, Guangqing Xiao, Snežana Milanović, et al.. (2023). A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects. Clinical Pharmacokinetics. 62(12). 1755–1763. 4 indexed citations

Xiao, Guangqing, et al.. (2022). In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia. Pharmaceutical Research. 39(5). 837–850. 11 indexed citations

Kumar, Vineet, Kazuya Ishida, Laurent Salphati, et al.. (2020). Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach. Drug Metabolism and Disposition. 49(2). 159–168. 27 indexed citations

Billington, Sarah, Laurent Salphati, Cornelis E. C. A. Hop, et al.. (2019). Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood–Brain Barrier Measured by Quantitative Targeted Proteomics. Clinical Pharmacology & Therapeutics. 106(1). 228–237. 60 indexed citations

Billington, Sarah, Steven C. Shoner, Scott D. Lee, et al.. (2019). Positron Emission Tomography Imaging of [¹¹C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A. Clinical Pharmacology & Therapeutics. 106(5). 1056–1066. 50 indexed citations

Kumar, Vineet, Laurent Salphati, Cornelis E. C. A. Hop, et al.. (2019). A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes Versus Human Liver Tissue Using Quantitative Targeted Proteomics and Cell Surface Biotinylation. Drug Metabolism and Disposition. 47(4). 350–357. 38 indexed citations

Ma, Bin, Brian S. Lucas, Andrew G. Capacci, et al.. (2019). Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators. Bioorganic & Medicinal Chemistry Letters. 30(4). 126852–126852. 30 indexed citations

Biliouris, Konstantinos, Ivan Nestorov, Himanshu Naik, et al.. (2018). A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans. Journal of Pharmacokinetics and Pharmacodynamics. 45(6). 817–827. 12 indexed citations

10.

Prasad, Bhagwat, Deepak Bhatt, Katherine Johnson, et al.. (2018). Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study. Drug Metabolism and Disposition. 46(7). 943–952. 72 indexed citations

11.

Xiao, Guangqing, et al.. (2018). Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K. Pharmaceutical Research. 35(8). 159–159. 9 indexed citations

12.

Prasad, Bhagwat, Andrea Gaedigk, Marc Vrana, et al.. (2016). Ontogeny of Hepatic Drug Transporters as Quantified by LC‐MS/MS Proteomics. Clinical Pharmacology & Therapeutics. 100(4). 362–370. 113 indexed citations

13.

Kraynov, Eugenia, Ajith V. Kamath, Markus Walles, et al.. (2015). Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper. Drug Metabolism and Disposition. 44(5). 617–623. 70 indexed citations

14.

Xiao, Guangqing & Liang‐Shang Gan. (2013). Receptor-Mediated Endocytosis and Brain Delivery of Therapeutic Biologics. International Journal of Cell Biology. 2013. 1–14. 118 indexed citations

15.

Mangravite, Lara M., Guangqing Xiao, & Kathleen M. Giacomini. (2003). Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. American Journal of Physiology-Renal Physiology. 284(5). F902–F910. 65 indexed citations

16.

Dresser, Mark J., Guangqing Xiao, Maya K. Leabman, Andrew T. Gray, & Kathleen M. Giacomini. (2002). Interactions of n-Tetraalkylammonium Compounds and Biguanides with a Human Renal Organic Cation Transporter (hOCT2). Pharmaceutical Research. 19(8). 1244–1247. 68 indexed citations

17.

Xiao, Guangqing, et al.. (2001). A Novel Proton-Dependent Nucleoside Transporter, CeCNT3, fromCaenorhabditis elegans. Molecular Pharmacology. 59(2). 339–348. 27 indexed citations

18.

Johnson, Robin J., et al.. (2001). Calreticulin functions as a molecular chaperone for the β-amyloid precursor protein 1 1Abbreviations used: Aβ, β-amyloid peptide; AD, Alzheimer’s disease; APP, β-amyloid precursor protein; CHAPS, 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propanesulfonate; Crt, calreticulin; DMEM, Dulbecco’s Modified Eagle Medium; DMJ, deoxymannojirimycin; DTSSP, 3,3′-Dithio bis (sulfosuccinimidylpropionate); ECL, Enhanced Chemiluminescence; ER, endoplasmic reticulum; FBS, fetal bovine serum; HRP, horseradish peroxidase; kDa, kiloDaltons; MES, 2-(N-Morpholino) ethane sulfonic acid; NRS, normal rabbit serum; PBS, PBS; PMSF, phenymethylsulfonyl fluoride; PVDF, polyvinylidene fluoride.. Neurobiology of Aging. 22(3). 387–395. 37 indexed citations

19.

Xiao, Guangqing, et al.. (1999). KDEL proteins are found on the surface of NG108-15 cells. Molecular Brain Research. 72(2). 121–128. 89 indexed citations

20.

Xiao, Guangqing, et al.. (1999). Calreticulin is transported to the surface of NG108-15 cells where it forms surface patches and is partially degraded in an acidic compartment. Journal of Neuroscience Research. 58(5). 652–662. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact